Literature DB >> 21360493

Acquisition of the rheumatoid arthritis HLA shared epitope through microchimerism.

Zhen Yan1, Tessa Aydelotte, V K Gadi, Katherine A Guthrie, J Lee Nelson.   

Abstract

OBJECTIVE: HLA-DRB1 alleles associated with risk of rheumatoid arthritis (RA) encode similar HLA-DRB1 sequences, called the shared epitope (SE). The most common SE sequences are QKRAA and QRRAA. Nevertheless, a substantial number of RA patients lack the SE. Bidirectional fetal-maternal trafficking results in long-term persistence of fetal cells in the mother and maternal cells in her offspring, a process known as microchimerism. This study was undertaken to discover whether RA patients who lack the SE can acquire it through microchimerism.
METHODS: We studied a total of 86 female subjects who were genotypically negative for the SE, comprising 52 patients with RA and 34 healthy controls. We developed specific real-time quantitative polymerase chain reaction assays for the SE-encoded sequences QKRAA and QRRAA, and used them to test DNA extracted from peripheral blood mononuclear cells.
RESULTS: Microchimerism with the SE was found significantly more often in RA patients than controls (odds ratio 4.1 [95% confidence interval 1.6-10.0], P = 0.003). Concentrations of SE microchimerism were also significantly higher among RA patients than controls (P = 0.002). In separate analyses for SE type, the prevalence of QKRAA microchimerism in RA patients versus healthy controls was 17% versus 3% (9 of 52 versus 1 of 34; P = 0.03) and the prevalence of QRRAA microchimerism was 40% versus 18% (21 of 52 versus 6 of 34; P = 0.04), respectively. Microchimerism concentrations were also higher in RA patients than healthy subjects for QKRAA (P = 0.03) and QRRAA (P = 0.03).
CONCLUSION: These results indicate that RA patients who genotypically lack the SE can acquire the SE as persistent microchimerism from fetal-maternal cell exchange, suggesting that SE-encoding microchimerism could be a risk factor for RA.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360493      PMCID: PMC3188444          DOI: 10.1002/art.30160

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

Review 1.  The molecular basis of susceptibility to rheumatoid arthritis.

Authors:  R Winchester
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

2.  Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history.

Authors:  Zhen Yan; Nathalie C Lambert; Katherine A Guthrie; Allison J Porter; Laurence S Loubiere; Margaret M Madeleine; Anne M Stevens; Heidi M Hermes; J Lee Nelson
Journal:  Am J Med       Date:  2005-08       Impact factor: 4.965

3.  An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility.

Authors:  Annette H M van der Helm-van Mil; Tom W J Huizinga; Geziena M Th Schreuder; Ferdinand C Breedveld; René R P de Vries; René E M Toes
Journal:  Arthritis Rheum       Date:  2005-09

4.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

5.  Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development.

Authors:  Anouk L Feitsma; Jane Worthington; Annette H M van der Helm-van Mil; Darren Plant; Wendy Thomson; Jennie Ursum; Dirkjan van Schaardenburg; Irene E van der Horst-Bruinsma; Jon J van Rood; Tom W J Huizinga; René E M Toes; René R P de Vries
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

6.  Non-inherited maternal human leukocyte antigen alleles in susceptibility to familial rheumatoid arthritis.

Authors:  K A Guthrie; N R Tishkevich; J L Nelson
Journal:  Ann Rheum Dis       Date:  2008-08-06       Impact factor: 19.103

7.  HLA heterozygosity contributes to susceptibility to rheumatoid arthritis.

Authors:  P Wordsworth; K D Pile; J D Buckely; J S Lanchbury; B Ollier; M Lathrop; J I Bell
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

8.  Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma.

Authors:  Nathalie C Lambert; Timothy D Erickson; Zhen Yan; Jennifer M Pang; Katherine A Guthrie; Daniel E Furst; J Lee Nelson
Journal:  Arthritis Rheum       Date:  2004-03

9.  The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture.

Authors:  Laura B Hughes; Dahliann Morrison; James M Kelley; Miguel A Padilla; L Kelly Vaughan; Andrew O Westfall; Harshit Dwivedi; Ted R Mikuls; V Michael Holers; Lezlie A Parrish; Graciela S Alarcón; Doyt L Conn; Beth L Jonas; Leigh F Callahan; Edwin A Smith; Gary S Gilkeson; George Howard; Larry W Moreland; Nick Patterson; David Reich; S Louis Bridges
Journal:  Arthritis Rheum       Date:  2008-02

10.  Non-inherited maternal HLA alleles are associated with rheumatoid arthritis.

Authors:  S Harney; J Newton; A Milicic; M A Brown; B P Wordsworth
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

View more
  27 in total

1.  Can maternal microchimeric cells influence the fetal response toward self antigens?

Authors:  Lucie Leveque; Kiarash Khosrotehrani
Journal:  Chimerism       Date:  2011-07-01

2.  Microchimerism in cord blood: mother as anticancer drug.

Authors:  William J Burlingham; J Lee Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

3.  Microchimerism in the rheumatoid nodules of patients with rheumatoid arthritis.

Authors:  William F N Chan; Christopher J Atkins; David Naysmith; Nicholas van der Westhuizen; Janet Woo; J Lee Nelson
Journal:  Arthritis Rheum       Date:  2012-02

4.  Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.

Authors:  JoonHo Lee; Roberto Romero; Yi Xu; Jung-Sun Kim; Ji Young Park; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Reprod Immunol       Date:  2011-09-27       Impact factor: 3.886

5.  Exosomes: The missing link between microchimerism and acquired tolerance?

Authors:  William J Burlingham
Journal:  Chimerism       Date:  2015-12-17

Review 6.  Fetomaternal immune cross-talk and its consequences for maternal and offspring's health.

Authors:  Petra C Arck; Kurt Hecher
Journal:  Nat Med       Date:  2013-05-07       Impact factor: 53.440

Review 7.  Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.

Authors:  Marcus Altfeld; Madeleine J Bunders
Journal:  Semin Immunopathol       Date:  2016-07-08       Impact factor: 9.623

Review 8.  Microchimerism: Defining and redefining the prepregnancy context - A review.

Authors:  H S Gammill; W E Harrington
Journal:  Placenta       Date:  2017-08-31       Impact factor: 3.481

9.  Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.

Authors:  Lynn D Haynes; Walker A Julliard; Joshua D Mezrich; Glen Leverson; Keith C Meyer; William J Burlingham
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

10.  Adverse pregnancy outcomes and risk of subsequent rheumatoid arthritis.

Authors:  Kimberly K Ma; J Lee Nelson; Katherine A Guthrie; Carin E Dugowson; Hilary S Gammill
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.